CLASSIFIEDSJul 20 2010 ↓Who Said What
Avastin, a drug primarily created by Roche to combat colon cancer showed tremendous promise for treating breast cancer as well. Yet the Food and Drug Administration has withdrawn its approval for the drug as a breast cancer medication 12 to 1 on grounds that Avastin, while promising, doesn’t really extend a patient’s life.
After more testing, it was said on Friday that the drug was not proven to extend women’s lives any more than other cancer treatments, such as chemotherapy.
Visit msnbc.com for breaking news, world news, and news about the economy
Avastin was originally given tentative approval as a drug to treat breast cancer when initial studies showed that the drug slowed the disease progress by a few months. The drug however did fail to proof that it also extended life.
According to Forbes:
“What really matters for a cancer drug is whether it helps the patient live longer. But those studies are very hard to do and take years. That’s why drug companies want to get drugs approved based on what are known as surrogate endpoints: Does the drug slow progression of the disease on a scan? Does it shrink tumors? But pretty-looking scans aren’t guaranteed to translate into fewer deaths. Maybe the disease will come back faster once the drug is stopped.”
Avastin not approved as breast cancer drug
A final decision will be made by the FDA after September 17 2010, when the FDA expects to receive the advisory panel’s recommendation regarding Avastin.
We understand the FDA’s position that life is a treasured commodity that must be preserved as long as possible. Still, to deny breast cancer patients, and for that matter, any other seriously ill individual, access to medications that possibly slows down the progress of this dreaded disease would be an injustice to those patients as they undoubtedly welcome any treatment that helps them with this awful illness, even if only a little bit.
Share This Article3 Responses to “FDA Rejects Breast Cancer Drug Avastin”
What's Your Opinion?
You must be logged in to post a comment.
Got A Story? Email it to our news desk at Tip Line @ Nodeju.com
Fast Growing Babies More Prone To Asthma
AMSTERDAM – Medical researchers already know that premature and underweight babies are much more susceptible to contracting Asthma than are babies who are considered to be within normal weight range… Full story
Handsize Baby Goes HomeLOS ANGELES – Considered to be one of the smallest babies in the world, no larger than the hand of a grown man and weighing less than a can of soda at the time she was born in August 2011, Melinda… Full story
Pfizer Loses 725 Million Dollars BERN – Swiss pharmaceutical giant Pfizer halted the research and production of a medication it had previously claimed was a ‘cure’ for Alzheimer disease. But now the company has come forth… Full story
17 Year Old Possibly Discovered Cancer Cure CUPERTINO – 17 year old Angela Zhang from Cupertino California, may have possibly developed a cure against cancer. Angela discovered a molecule that she describes as the “Swiss Knife” of all… Full story
Woman Coughs Out Tumor LONDON – Claire Osborn was given a death sentence by her doctor who told her that the tissue piece she coughed up a few weeks ago was cancer. Osborn was told by her doctor that she had an… Full story
Recent Searches for avastin 
Madonna And The Super Bowl
Fidel Castro Back In The Public Eye
When Police Strike, Murders Increase
Internet Cafe Users A Suspicious Bunch?
West-Africa Drought Kills Wild Life
Fukushima Leaking Again
Syrian Troops Keep On Killing Citizens
Vermont Prisoners Embarrass Cops
VeriSign Inc Site Hacked
Obama To Appear On American Idol?
The First Americans Were Russians
[...] » FDA Rejects Breast Cancer Drug Avastin [...]
[...] FDA Rejects Breast Cancer Drug Avastin – Nodeju.com Logo [...]
[...] NDJ World | News Hot Trends and Views [...]